伊藤 逸毅

Medicine & Life Sciences

1. Eye 100%
2. Optical Coherence Tomography 66%
3. Macular Degeneration 39%
4. Retinal Perforations 35%
5. Visual Acuity 31%
6. Retina 31%
7. Photochemotherapy 30%
8. aflibercept 27%
9. Angiography 27%
10. Vitrectomy 26%
11. Retinal Detachment 26%
12. Intravitreal Injections 23%
13. Retinitis Pigmentosa 20%
14. Macular Edema 20%
15. Central Serous Chorioretinopathy 20%
16. Optic Disk 19%
17. Bevacizumab 18%
18. Retinal Vein Occlusion 17%
19. Diabetic Retinopathy 17%
20. Choroidal Neovascularization 17%
21. Indocyanine Green 13%
22. Retinopathy of Prematurity 13%
23. Membranes 12%
24. Retinal Pigment Epithelium 12%
25. Lasers 11%
26. Visual Fields 10%
27. Subretinal Fluid 10%
28. Choroid 10%
29. Silicone Oils 9%
30. Bestrophinopathy 9%
31. brolucizumab 9%
32. Epiretinal Membrane 8%
33. Retinal Vessels 8%
34. Depth Perception 8%
35. Japan 8%
36. Fluorocarbons 8%
37. Oxygen 7%
38. Aqueous Humor 7%
39. Triamcinolone Acetonide 7%
40. Acute zonal occult outer retinopathy 7%
41. Injections 7%
42. Blood Vessels 7%
43. Color Vision Defects 7%
44. Nose 7%
45. Therapeutics 6%
46. Registries 6%
47. Intraocular Lenses 6%
48. Nerve Fibers 6%
49. Retinal Artery Occlusion 5%
50. Perfusion 5%